Viral and Bacterial Etiology of Common Respiratory Infections in Children in Sub-Saharan Africa: A Systematic Review

Jordy Exaucé Demboux Lyelet1,2, Pembe Issamou Mayengue1,2,3, Félix Koukouikila-Koussounda1,2

  • 1Faculty of Sciences and Technics, Marien Ngouabi University, Brazzaville BP 69, Congo.

PubMed

Insights

Acute respiratory infections in sub-Saharan Africa are mainly caused by viruses like respiratory syncytial virus and rhinovirus, along with bacteria such as Streptococcus pneumoniae.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Pediatrics

Background:

  • Respiratory infections pose significant global health challenges, particularly impacting children under five in developing nations.
  • Accurate etiological data is essential for effective prevention and management of respiratory infections.
  • Sub-Saharan Africa faces a high burden of respiratory infections, necessitating localized epidemiological understanding.

Purpose of the Study:

  • To review and synthesize the etiological data of respiratory infections in sub-Saharan Africa.
  • To identify the primary viral and bacterial agents responsible for these infections in the region.
  • To inform public health strategies for respiratory infection control in sub-Saharan Africa.

Main Methods:

  • A comprehensive literature search was conducted using PubMed, HINARI, and Google Scholar.
  • Studies published between 2010 and 2023, focusing on sub-Saharan Africa, were included.
  • Data from 50 selected articles, representing 24 countries, were analyzed.

Main Results:

  • Respiratory syncytial virus and rhinovirus were the most frequently identified viral pathogens.
  • Streptococcus pneumoniae and Haemophilus influenzae were the predominant bacterial agents identified.
  • The majority of included studies were cross-sectional and hospital-based.

Conclusions:

  • Viral agents, notably respiratory syncytial virus and rhinovirus, are the leading causes of acute respiratory infections in children in sub-Saharan Africa.
  • Key bacterial pathogens like Streptococcus pneumoniae and Haemophilus influenzae also contribute significantly to the burden of these infections.
  • This review highlights the critical need for targeted interventions addressing both viral and bacterial etiologies to combat respiratory infections in the region.

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.3K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.6K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
731
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.1K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
629
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
756